Convalescent Plasma to Stem Coronavirus in COVID negative participants (CSSC-001)
Research Question:
Does blood plasma from people who are recovered from COVID-19 infection help prevent
COVID-19 infection when given to others?
Basic Study Information
Purpose:
This study will determine if plasma collected from the blood of people who have recovered
from COVID-19 infection will help others who are at risk for getting COVID-19. Participants
should be people who are at high risk for COVID-19 infection. They will receive a
one-time infusion of convalescent or control plasma. Convalescent plasma is from a
person who has recovered from a COVID-19 infection. Plasma will not have COVID-19
but will have antibodies to the virus. The purpose of this study is to determine
if these antibodies will help keep people who are at high risk for getting COVID from
getting infected. To be eligible you must have had close contact with someone who
is COVID-19 positive and have a high risk for illness such as >=65, reside in a nursing
home or long-term care facility, have chronic lung disease, asthma, heart disease,
obesity, uncontrolled diabetes, renal failure, liver disease or cancer. Or you must
be a healthcare professional with high risk exposure such as have had prolonged close
contact with patients with COVID-19 who were not wearing a facemask while HCP nose
and mouth were exposed to material potentially infectious with the virus causing COVID-19.
Location: University of Rochester
Study Reference #: 4964
Lead Researcher (Principal Investigator)
Lead Researcher:
Martin Zand
Study Contact Information
Study Coordinator: Susanne Heininger
Phone: (585) 273-1926
Email: Susanne_Heininger@URMC.Rochester.edu
Additional Study Details
Number of Visits:
2 to 5
Parking:
Free
Transportation Coverage:
No
Reimbursement:
Yes
Trial Not Found
The study you are looking for is not active at this time.
Return to Search